Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser

Dermatologic Surgery

Volumn 22, Issue 1, 1996, Pages 33-37

  Ellis, Darrel L ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; DOXEPIN; RANITIDINE;

ARTICLE; CASE REPORT; DYE LASER; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LASER SURGERY; MAST CELL; PRIORITY JOURNAL; SCHOOL CHILD; SKIN NECROSIS; TELANGIECTASIA; URTICARIA; URTICARIA PIGMENTOSA;

EID: 0030069851     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1996.tb00568.x     Document Type: Article

References (11)

1. Weber FP, Hellenschmied R. Telangiectasia macularia eruptiva perstans. Br J Dermatol 1930;42:374-82.
2. Demis DJ, Walton MD, Higdon RS. Histaminuria in urticaria pigmentosa: a clinical study and review of recent literature with definition of the mastocytosis syndrome. Arch Dermatol 1961;83: 127-38.
3. Demis DJ. The mastocytosis syndrome: clinical and biological studies. Ann Intern Med 1963;59:194-206.
4. Travis WD, Li C-Y, Bergstralh EJ, et al. Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 1988;67:345-68.
5. Scott HW Jr, Parris WCV, Sandidge PC, et al. Hazards in operative management of patients with systemic mastocytosis. Ann Surg 1983;197:507-14.
6. Parris WCV, Scott HW, Smith BE. Anesthetic management of systemic mastocytosis: Experience with 42 cases. Anesth Anaig 1986;65:S117.
7. Goins VA. Mastocytosis: perioperative considerations. AORN J 1991;54:1227-38.
8. Sullivan TJ. Pharmacologic modulation of the whealing response to histamine in human skin: identification of doxepin as a potent in vivo inhibitor. J Allergy Clin Immunol 1982;69:260-7.
9. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rall TW, and Murad F, eds. The Pharmacologic Basis of Therapeutics, 7th ed. New York: MacMillan Publishing Co., 1985, 413-23.
10. Longley BJ Jr, Morganroth GS, Tyrrell L, et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993,328:1302-7.
11. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328:257-65.